Most Recent
Construction PRO
A judge has granted interim freezing orders against Star Investment Group Australia and its director after finding reasonable grounds to suspect it misled investors while promoting a development scheme in regional Victoria.
Western Australia-based wagering company Playwest has sued Apple after its app was removed from the App Store without notice over alleged fraud concerns.
Settling a split in authorities from the 19th century, an appeals court has found that a solicitor’s lien applies over all money held in a client’s trust account and covers the costs of enforcing unpaid legal fees, not just the bill itself.
Defunct Westpac subsidiary RAMS Financial Group has agreed to settle a class action over the termination of franchise agreements.
The Full Court has rejected trading platform Plus500's bid to stay a class action by investors who lost money on highly leveraged contracts for difference in light of an arbitration clause in its terms and conditions, upholding a finding that the clause was an unfair contract term.
The state of Victoria wants to declass a representative proceeding brought on behalf of climate protesters over Victoria Police's use of pepper spray, telling a judge it is prepared to negotiate individually with the 50 group members.
Construction PRO
Melbourne builder Cobolt Constructions has sued over a SOPA ruling that blocked it from recovering $735,000 for works at a social housing development in Brunswick because its payment claim was served one day late.
A law firm has won a 39 per cent cut of a $27 million class action settlement with vehicle leasing company FleetPartners, the largest contingency fee percentage awarded to date.
Construction PRO
A judge has ruled that reality television personality Venous Behbahani-Clark was not validly gifted a $2 million Toorak home by her sister and the sister's ex-husband Alex Waislitz, resolving proceedings the judge called lengthy and disproportionate.
Pfizer has lost a patent infringement lawsuit against Samsung Bioepis over the generic version of its blockbuster autoimmune drug Enbrel, with a judge finding all but one of the patent's claims is invalid.